← All companies

VIR

Vir Biotechnology, Inc.

VIR Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$8.90

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$1.50B

Revenue (TTM)

$65.5M

Net income (TTM)

-$443M

EPS (TTM)

$-3.13

P/E ratio

—

Dividend yield

—

Free cash flow

-$397M

Cash

$274M

Total assets

$1.03B

Gross margin

—

52-week range

$4.16 – $11.66

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 24, 2026 8-K Director or officer change Jun 10, 2026 8-K Director or officer change; Shareholder vote results May 28, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Director or officer change Apr 10, 2026 8-K Director or officer change Mar 4, 2026 8-K Other events Mar 2, 2026 8-K Entered a material agreement Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 23, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Other events Feb 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement; Other events Dec 16, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Other events Jul 24, 2025 8-K Shareholder vote results May 29, 2025 8-K Other events May 9, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Director or officer change Jan 30, 2025 8-K Regulation FD disclosure; Other events Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K Completed an acquisition or disposition; Director or officer change; Regulation FD disclosure Sep 10, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release); Exit or disposal costs Aug 1, 2024 8-K Entered a material agreement Aug 1, 2024 8-K Other events Jun 26, 2024 8-K Regulation FD disclosure Jun 5, 2024 8-K Shareholder vote results May 29, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Director or officer change; Other events Apr 18, 2024 10-K Fiscal year ended 2023-12-31 Feb 26, 2024 8-K Entered a material agreement; Results of operations (earnings release) Feb 22, 2024